(MedPage Today) — Could be record year for new drug approvals
Direct funduscopy exams performed infrequently, finds Loyola study
For more than 150 years, physicians have examined patients’ eyes with a lighted, hand-held instrument called an ophthalmoscope.
Uncategorized
VIDEO: RPE detachments respond to ranibizumab in HARBOR trial
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, David A. Eichenbaum, MD, discusses the relationship between macular atrophy, retinal pigment epithelial detachment and response to treatment with ranibizumab in the HARBOR trial.
D.C. Week: Mostly Smooth Sailing for FDA Nominee at Senate Hearing
(MedPage Today) — The FDA releases a report on potentially dangerous laboratory developed tests
Uncategorized
VIDEO: Surgeon introduces new accommodating IOL technology
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Uday Devgan, MD, discusses the advantages of a new accommodating IOL technology from LensGen.
Uncategorized
Amniotic membrane transplantation may prevent ocular sequelae in Stevens-Johnson syndrome
LAS VEGAS — Ocular sequelae from Stevens-Johnson syndrome may be prevented with amniotic membrane transplantation when applied within the first 6 days after symptom onset, according to a paper presentation here. “Medical management is appropriate for patients who have more mild ocular manifestations, and this often includes various combinations of antibiotics, topical steroids, as well as cyclosporine and lubrication,” Amy Marie Cherof, MD, said at the American Academy of Ophthalmology annual meeting. “In addition, amniotic membrane transplantation has been shown in many studies, including those of our own, to decrease the risk of this chronic cicatricial change.”